HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of EMLA cream to reduce fear and pain associated with interferon beta-1a injection in patients with multiple sclerosis.

Abstract
Fear of pain from injections may affect adherence to needed drug therapy. A single-blind, placebo-controlled crossover study was conducted to evaluate the efficacy of EMLA cream in reducing the fear and pain associated with intramuscular (IM) injection during administration of interferon beta-1a to patients with multiple sclerosis. Patients rated fear of injection on a visual analog scale before the injection and rated injection pain following the injection. With the application of EMLA cream, the mean pain-of-injection score was found to be significantly lower than the mean fear-of-injection score. The 18 patients who completed the study experienced a statistically significant decrease in both scores. This study suggests that the use of EMLA cream may reduce the pain and fear associated with IM injections.
AuthorsMarijean Buhse
JournalThe Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses (J Neurosci Nurs) Vol. 38 Issue 4 Pg. 222-6 (Aug 2006) ISSN: 0888-0395 [Print] United States
PMID16924997 (Publication Type: Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adjuvants, Immunologic
  • Anesthetics, Local
  • Lidocaine, Prilocaine Drug Combination
  • Ointments
  • Prilocaine
  • Interferon-beta
  • Lidocaine
  • Interferon beta-1a
Topics
  • Adjuvants, Immunologic (administration & dosage)
  • Administration, Cutaneous
  • Adolescent
  • Adult
  • Anesthetics, Local (therapeutic use)
  • Attitude to Health
  • Clinical Nursing Research
  • Cross-Over Studies
  • Fear (drug effects, psychology)
  • Female
  • Humans
  • Injections, Intramuscular (adverse effects)
  • Interferon beta-1a
  • Interferon-beta (administration & dosage)
  • Lidocaine (therapeutic use)
  • Lidocaine, Prilocaine Drug Combination
  • Male
  • Middle Aged
  • Multiple Sclerosis, Relapsing-Remitting (drug therapy, psychology)
  • Ointments
  • Pain (diagnosis, etiology, prevention & control)
  • Pain Measurement
  • Pilot Projects
  • Prilocaine (therapeutic use)
  • Single-Blind Method
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: